Related Experiment Video
Updated: Jun 28, 2025
The Microscopy-Based Assay to Study and Analyze the Recycling Endosomes using SNARE Trafficking
Published on: February 12, 2022
A systematic computational analysis of the endosomal recycling pathway in glioblastoma
Luke J Joyce1, Andrew J Lindsay1
1Membrane Trafficking and Disease Laboratory, School of Biochemistry & Cell Biology, Biosciences Institute, University College Cork, Cork, T12 YT20, Ireland.
Abstract:
Glioblastoma (GBM) is the most common and aggressive brain cancer in adults. The standard treatment is brutal and has changed little in 20 years, and more than 85% of patients will die within two years of their diagnosis. There is thus an urgent need to identify new drug targets and develop novel therapeutic strategies to increase survival and improve quality of life. Using publicly available genomics, transcriptomics and proteomics datasets, we compared the expression of endosomal recycling pathway regulators in non-tumour brain tissue with their expression in GBM. We found that key regulators of this pathway are dysregulated in GBM and their expression levels can be linked to survival outcomes. Further analysis of the differentially expressed endosomal recycling regulators allowed us to generate an 8-gene prognostic signature that can distinguish low-risk from high-risk GBM and potentially identify tumours that may benefit from treatment with endosomal recycling inhibitors. This study presents the first systematic analysis of the endosomal recycling pathway in glioblastoma and suggests it could be a promising target for the development of novel therapies and therapeutic strategies to improve outcomes for patients.
Insights
Glioblastoma (brain cancer) research reveals new drug targets. An 8-gene signature identifies patient risk and potential response to endosomal recycling inhibitors, offering hope for improved glioblastoma treatments.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Genomics
Background:
- Glioblastoma (GBM) is an aggressive brain cancer with poor prognosis.
- Current treatments are largely ineffective, necessitating new therapeutic strategies.
- Identifying novel drug targets is critical for improving patient survival and quality of life.
Purpose of the Study:
- To investigate the role of the endosomal recycling pathway in glioblastoma.
- To identify potential therapeutic targets within this pathway.
- To develop a prognostic signature for glioblastoma patients.
Main Methods:
- Analysis of publicly available genomics, transcriptomics, and proteomics datasets.
- Comparison of endosomal recycling pathway regulator expression in GBM versus non-tumour brain tissue.
- Development of an 8-gene prognostic signature based on differentially expressed genes.
Main Results:
- Key regulators of the endosomal recycling pathway are significantly dysregulated in glioblastoma.
- Expression levels of these regulators correlate with patient survival outcomes.
- An 8-gene signature effectively distinguishes between low-risk and high-risk glioblastoma patients.
Conclusions:
- The endosomal recycling pathway represents a promising therapeutic target for glioblastoma.
- The 8-gene prognostic signature can aid in risk stratification and treatment selection.
- Targeting endosomal recycling may lead to novel therapies to improve glioblastoma patient outcomes.
Related Concept Videos
00:58Recycling Endosomes and Transcytosis
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
01:45ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...